AI health care firms face increasing state law compliance concerns

We recently hosted our 3rd annual AI Health Law & Policy Summit in Washington, DC where government and industry representatives joined members of the Hogan Lovells team to discuss new and emerging global health care AI policies. The article below is part of a series sharing key takeaways from the program.

With more than 600 state-level proposed bills focused on AI, Mark Brennan, partner in Hogan Lovells’ Communications, Internet, and Media practice, joined industry representatives to discuss ongoing state and local governments’ debates over whether to regulate AI as part of their public health initiatives, including related employment and educational efforts. Mr. Brennan emphasized the importance of ensuring that any new regulation continues to support positive public health outcomes, mentioning how AI may be beneficial there.

The panelists considered how several bills – which have some momentum in various states – would require risk management plans, disclosure and transparency obligations, and anti-discrimination pledges from deployers of AI systems. Mr. Brennan predicted this will continue to be a complex, unsettled area of regulatory policy for the next few years, at both the federal and state levels.


This website is operated by Hogan Lovells International LLP, whose registered office is at Atlantic House, Holborn Viaduct, London, EC1A 2FG. For further details of Hogan Lovells International LLP and the international legal practice that comprises Hogan Lovells International LLP, Hogan Lovells US LLP and their affiliated businesses ("Hogan Lovells"), please see our Legal Notices page. © 2024 Hogan Lovells.

Attorney advertising. Prior results do not guarantee a similar outcome.